6,867
Views
10
CrossRef citations to date
0
Altmetric
Short Report

Concentration of fecal calprotectin in 11,255 children aged 0–18 years

&
Pages 1024-1027 | Received 22 May 2020, Accepted 03 Jul 2020, Published online: 15 Jul 2020

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Anna-Maija Puolanne, Sami Qadri, Tiina Vesterinen, Saara Hiltunen, Aaro Mustonen, Samu Kurki, Kaija-Leena Kolho, Johanna Arola & Martti Färkkilä. (2022) Can dysplasia surveillance be better targeted in ulcerative colitis by using faecal calprotectin?. Scandinavian Journal of Gastroenterology 57:11, pages 1304-1311.
Read now

Articles from other publishers (9)

Melanie L. Schmidt, Emma McCrady, Angus Lee, Terrence Bowerbank, Michael R. Miller, Melanie Watson, Ashok Dhandapani, Jessica P. Woolfson, Andréanne N. Zizzo, Kevin Bax & Eileen Crowley. (2024) Home‐based fecal calprotectin utilization in a general pediatric gastroenterology clinic. Journal of Pediatric Gastroenterology and Nutrition 78:4, pages 790-799.
Crossref
A. A. Kamalova, G. A. Garina, I. Kh. Valeeva & A. R. Gaifutdinova. (2023) Fecal calprotectin as a marker of inflammatory bowel diseases. Rossiyskiy Vestnik Perinatologii i Pediatrii (Russian Bulletin of Perinatology and Pediatrics) 68:5, pages 138-143.
Crossref
Margo B. Heston, Kendra L. Hanslik, Katie R. Zarbock, Sandra J. Harding, Nancy J. Davenport-Sis, Robert L. Kerby, Nathaniel Chin, Yi Sun, Ana Hoeft, Yuetiva Deming, Nicholas M. Vogt, Tobey J. Betthauser, Sterling C. Johnson, Sanjay Asthana, Gwendlyn Kollmorgen, Ivonne Suridjan, Norbert Wild, Henrik Zetterberg, Kaj Blennow, Federico E. Rey, Barbara B. Bendlin & Tyler K. Ulland. (2023) Gut inflammation associated with age and Alzheimer’s disease pathology: a human cohort study. Scientific Reports 13:1.
Crossref
Maria Hemming-Harlo, Laura Merras-Salmio, Anne Nikkonen & Kaija-Leena Kolho. (2023) Drug levels of VEDOLIZUMAB in patients with pediatric-onset inflammatory bowel disease in a real-life setting. European Journal of Pediatrics 183:1, pages 313-322.
Crossref
Luyang Hong, Yihuang Huang, Siyuan Jiang, Junyan Han, Shujuan Li, Lan Zhang, Qi Zhou, Xincheng Cao, Weiyin Yu, Yi Yang & Yun Cao. (2023) Postnatal Dynamics and Clinical Associations of Fecal Calprotectin in Very Preterm Infants: Implications for Necrotizing Enterocolitis and Feeding Intolerance. Clinical and Translational Gastroenterology Publish Ahead of Print.
Crossref
Katariina Koivusaari, Sari Niinistö, Jaakko Nevalainen, Jarno Honkanen, Terhi Ruohtula, Mirva Koreasalo, Suvi Ahonen, Mari Åkerlund, Heli Tapanainen, Heli Siljander, Maija E. Miettinen, Tapani Alatossava, Jorma Ilonen, Outi Vaarala, Mikael Knip & Suvi M. Virtanen. (2023) Infant Feeding, Gut Permeability, and Gut Inflammation Markers. Journal of Pediatric Gastroenterology & Nutrition 76:6, pages 822-829.
Crossref
Zhifei Liu, Yue-Mei Fan, Per Ashorn, Chilungamo Chingwanda, Kenneth Maleta, Lotta Hallamaa, Heikki Hyöty, David Chaima & Ulla Ashorn. (2022) Lack of Associations between Environmental Exposures and Environmental Enteric Dysfunction among 18-Month-Old Children in Rural Malawi. International Journal of Environmental Research and Public Health 19:17, pages 10891.
Crossref
Pavel Frühauf. (2022) Fecal calprotectin. Pediatrie pro praxi 23:3, pages 243-244.
Crossref
Carmen Ribes Koninckx, Ester Donat, Marc A. Benninga, Ilse J. Broekaert, Frederic Gottrand, Kaija‐Leena Kolho, Paolo Lionetti, Erasmo Miele, Rok Orel, Alexandra Papadopoulou, Corina Pienar, Michela G. Schäppi, Michael Wilschanski & Nikhil Thapar. (2021) The Use of Fecal Calprotectin Testing in Paediatric Disorders. Journal of Pediatric Gastroenterology and Nutrition 72:4, pages 617-640.
Crossref